PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?

In the article, a role of percutaneous intervention discussed in stable ischemic disease of the heart, and an evolution presented of the perspectives on its influence on prognosis and clinical presentation of the disease. The results provided, of recent trials, including the ORBITA. According to cur...

Full description

Bibliographic Details
Main Authors:	Yu. A. Karpov, I. L. Kozlovskaya, O. S. Bulkina, V. V. Lopukhova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2018-04-01
Series:	Российский кардиологический журнал
Subjects:	percutaneous coronary intervention stable ischemic disease angina pectoris
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2686

Similar Items

Effect of preinfarction angina on primary percutaneous coronary intervention outcomes
by: Hamid Reza Sanati, et al.
Published: (2018-01-01)

Ivabradinum supplements the clinical efficacy of percutaneous coronary intervention in patients with coronary heart disease with stable angina
by: D. M Aronov, et al.
Published: (2017-06-01)

Effect of Opium Addiction on Aspirin Resistance in Stable Angina Pectoris
by: Afsaneh Forood, et al.
Published: (2014-01-01)

Advantages of percutaneous coronary intervention in relation to medication therapy in patients with stable angina pectoris ( three-wessel coronary disease)
by: Milićević Nemanja, et al.
Published: (2018-01-01)

Intracoronary Adenosine to Prevent Myonecrosis in Patients with Stable Angina Undergoing Percutaneous Interventions: A Double-Blinded Randomized Controlled Trial
by: HamidReza Sanati, et al.
Published: (2015-10-01)

ORIGINAL PAPER <br>Dynamics of changes of the BNP concentration in patients with stable angina pectoris qualified for PTCA. Dependence on the selected morphological and haemodynamic parameters
by: Robert Irzmański, et al.
Published: (2006-03-01)

Epicardial Fat Thickness as a Diagnostic Marker of Coronary Lesions in Stable Angina Pectoris Patients
by: Ulzim Fajar
Published: (2021-03-01)

A critical appraisal of the pharmacological management of stable angina
by: Dimitrios Farmakis, et al.
Published: (2021-03-01)

Predictors of Long-Term Mortality in Patients with Stable Angina Pectoris and Coronary Slow Flow
by: Sukru Aksoy, et al.
Published: (2023-04-01)

Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial
by: Joyce M. Heutinck, et al.
Published: (2023-05-01)

Nicorandil in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention: literature review
by: Neda Partovi, et al.
Published: (2015-01-01)

Nicorandil in patients with acute coronary syndrome and stable angina undergoing Percutaneous Coronary Intervention: literature review
by: Neda Partovi, et al.
Published: (2014-12-01)

Propranolol treatment ofeffort angina in patients with arterial hypotension
by: E M Idrisova, et al.
Published: (2004-08-01)

Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris
by: V. V. Kashtalap, et al.
Published: (2019-11-01)

A New Biomarker in The Distinction Between Stable Coronary Artery Disease and Acute Coronary Syndrome:Thiols
by: Fatih Balcı, et al.
Published: (2022-07-01)

Heart rate variability in patients with stable angina pectoris as a risk factor for adverse clinical prognosis: relationship with affective depressive symptoms
by: A. O. Lobe, et al.
Published: (2020-12-01)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01)

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
by: A. G Evdokimova, et al.
Published: (2016-06-01)

Comparison of the safety and efficacy of ivabradine and nebivolol mono- and combination therapies in the treatment of stable angina pectoris patients with left ventricular dysfunction
by: Rasim Kutlu, et al.
Published: (2013-06-01)

Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina?
by: Daniela Benedetto, et al.
Published: (2016-10-01)

TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR
by: I. M. Sokolov
Published: (2016-01-01)

MODERN DRUG THERAPY OF THE CHRONIC STABLE ANGINAE (REVIEW)
by: V. P. Lupanov
Published: (2017-11-01)

Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study
by: Alexander C. Fanaroff, et al.
Published: (2017-10-01)

Relation of IL-1?, IL-5, IL-6 and IL-8 with stable angina pectoris
by: Hamza A. Khalid, et al.
Published: (2023-04-01)

Stable angina and heart rate
by: A. A Kirichenko
Published: (2018-09-01)

Plasma α1-antitrypsin: A Neglected Predictor of Angiographic Severity in Patients with Stable Angina Pectoris
by: Hui Zhao, et al.
Published: (2015-01-01)

Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment
by: Indu Dhar, et al.
Published: (2022-12-01)

PROGNOSTIC VALUE OF P-SELECTIN IN PATIENTS WITH STABLE ANGINA PECTORIS
by: Khvysiuk M. O., et al.
Published: (2018-07-01)

Remarks on Angina Pectoris
by: Sabino Scardi, et al.
Published: (2005-03-01)

Angina de Prinzmetal Angina de Prinzmetal Prinzmetal's angina
by: Eduardo Contreras Zuniga, et al.
Published: (2009-08-01)

MULTISLICE COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY IN PATIENTS WITH ANGINA PECTORIS
by: D. Ilić, et al.
Published: (2016-04-01)

THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
by: I. I. Sinitsina, et al.
Published: (2015-12-01)

Manejo farmacológico de la angina
by: Jorge Jalil Milad
Published: (2017-03-01)

The Relationship Between Serum Vaspin Levels and the Degree of Coronary Involvement in Patients with Stable Angina Pectoris
by: İlter Bozacı, et al.
Published: (2020-03-01)

THE ROLE OF PULSE REDUCTION THERAPY IN ADDITIONAL IMPROVEMENT OF CLINICAL EFFECTS OF MYOCARDIAL REVASCULARIZATION IN CORONARY HEART DISEASE STABLE ANGINA PATIENTS
by: D. M. Aronov, et al.
Published: (2018-06-01)

Using Two-Dimensional Speckle Tracking Echocardiography to Predict Coronary Artery Disease Severity in Patients with Chronic Stable Angina
by: Ibrahim Said, et al.
Published: (2023-05-01)

Percutaneous coronary intervention versus optimal medical therapy for stable coronary artery disease: An umbrella review
by: David R. Soriano-Moreno, et al.
Published: (2024-03-01)

TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA)
by: S. Yu. Martsevich, et al.
Published: (2018-07-01)

The influence of prolactin serum level on myocardial ischemia in patients with stable angina and gastroesophageal reflux disease
by: O.S. Khukhlina, et al.
Published: (2019-10-01)

CHANGES IN THE CYTOKINE STATUS WITH STABLE ANGINA
by: E. K. Gordeeva, et al.
Published: (2016-03-01)